Gene therapy: the tailor-made treatment
June 28, 2006Research and Development drug development, gene therapy
At the risk of boring my audience, I really can't help beginning with yet another attack of nostalgia ,or rather …
Calling up reinforcements
June 28, 2006Business Services interim management, recruitment
In the pharmaceutical industry outsourcing has never enjoyed greater popularity and all the indications are that this trend is set …
New drug for treatment-resistant HIV approved
June 28, 2006Sales and Marketing
Prezista, a new drug for patients who have treatment-resistant HIV, has been approved in the US.The treatment from Johnson & …
Novartis to market new vaccine for Japanese encephalitis
June 28, 2006Sales and Marketing
Novartis has licensed the marketing rights to a phase III vaccine from Intercell for Japanese encephalitis virus infections. The vaccine …
J&J buys Pfizer consumer health division for $16 billion
June 27, 2006Sales and Marketing
Healthcare conglomerate Johnson & Johnson is to buy Pfizer's consumer health division for more than $16 billion, a move which …
Novartis buys Manchester-based biotech and superbug drugs
June 21, 2006Research and Development
UK biotech NeuTec is to be acquired by Swiss pharma giant Novartis which says the company's two anti-infective drug candidates …
Schering-Plough named in top 50 best places to work in UK
June 20, 2006Business Services careers
Schering-Plough UK has been named as one of best places to work in the country, based on a survey of …
Study shows Inegy scores over its rival Crestor
June 19, 2006Sales and Marketing
A head-to-head study on the combination cholesterol-lowering drug, Inegy, has shown that it could be more effective than one of …
Bayer clinches Schering purchase
June 16, 2006Sales and Marketing
The tussle between Merck KGaA and Bayer for control of fellow German pharma company Schering has been settled, with Merck …
Ringing the changes in pharmaceutical sales
June 16, 2006Sales and Marketing sales, strategy
Every business and every market is unique, but there is a huge expanse of common ground when it comes to …
Galvus could offer hope to difficult-to-treat diabetes patients
June 16, 2006Sales and Marketing
Galvus, a new antidiabetic drug that appears to limit the weight gain and fluid retention which often occurs with other …
GPs launch scathing attack on health service reforms
June 16, 2006Government reforms and targets for the health service have come under a scathing and comprehensive attack from general practitioners, who …
Allergan chooses UK for research base
June 16, 2006Allergan
US specialist pharmaceutical company Allergan has opened its new European research and development operations in Marlow in Buckinghamshire.Allergan is the …
Switching scripts: the impact of NHS reforms
June 15, 2006Sales and Marketing NHS, healthcare, sales, strategy
During 2006/7, the NHS in England will see an unprecedented level of change within primary care with the reconfiguration of …
Top Pharmaceutical Employers
June 14, 2006careers
AstraZenecaAstraZeneca, the UK's second biggest home-grown big pharma company has continued to thrive over the last few years, despite some …
Cancer vaccine continues to show encouraging results
June 14, 2006Research and Development
Oxford BioMedica, the UK gene therapy specialist, has reported encouraging results from five phase II studies of TroVax, its leading …
Combination pill cuts heart attacks
June 13, 2006Sales and Marketing
New data on Pfizer's combination pill Caduet show it can cut the number of heart attacks and strokes in at-risk …
Blockbuster potential for diabetes vision drug
June 13, 2006Research and Development, Sales and Marketing
Lilly says new phase III data on its drug Arxxant shows it can stop diabetes patients losing their sight.Data from …
True scale of NHS deficits ‘masked’ says think tank
June 9, 2006Figures showing the NHS with debts of 512 million pounds are masking the true extent of the crisis, according to …
Relief for campaigners as NICE approves Herceptin
June 9, 2006Breast cancer drug campaigners have breathed a sigh of relief after NICE said Herceptin should be used to treat women …
Latest content
FibroFind appoints Lee Borthwick as CEO
